What is GeneDx Holdings's other commercial liabilities?

GeneDx Holdings (WGS) reported other commercial liabilities of $24.66M in Q1 2026.

How has GeneDx Holdings's other commercial liabilities changed year-over-year?

GeneDx Holdings's other commercial liabilities increased by 75.8% year-over-year, from $14.03M to $24.66M.

What is the long-term trend for GeneDx Holdings's other commercial liabilities?

Over 5 years (2020 to 2025), GeneDx Holdings's other commercial liabilities has grown at a 30.4% compound annual growth rate (CAGR), from $11.85M to $44.66M.

GeneDx Holdings WGS Other Commercial Liabilities

Other Commercial Liabilities at other companies

Tempus AI, Inc.TEM

——

RevvityRVTY

——

Labcorp HoldingsLH

——

IlluminaILMN

——

Guardant HealthGH

——

Adaptive BiotechnologiesADPT

——

Other financials

Income statement

See full

Revenue$102.3M+17.4%

Gross profit$68.2M+16.6%

Operating income-$57.5M-1,163%

Net income-$63.3M-870%

EPS (diluted)-$2.16-839%

Balance sheet

See full

Cash & equivalents$94.9M-5.7%

Total debt$96.7M+82.5%

Total equity$254.1M-1.3%

Total assets$506.3M+13.4%

Cash flow

See full

Operating cash flow-$32.4M-418%

CapEx$6.5M+5.3%

Free cash flow-$38.9M-1,059%

Valuation

See full

Market cap$1.72B-24.3%

Enterprise value$1.73B-22.8%

P/S3.9×-3.0×

Profitability

See full

Gross margin69.6%+4.3pp

Operating margin-14.9%—

Net margin-17.6%—

FCF margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-30.4%—

Debt / equity0.4×+0.2×

Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is GeneDx Holdings's other commercial liabilities?: GeneDx Holdings (WGS) reported other commercial liabilities of $24.66M in Q1 2026.
How has GeneDx Holdings's other commercial liabilities changed year-over-year?: GeneDx Holdings's other commercial liabilities increased by 75.8% year-over-year, from $14.03M to $24.66M.
What is the long-term trend for GeneDx Holdings's other commercial liabilities?: Over 5 years (2020 to 2025), GeneDx Holdings's other commercial liabilities has grown at a 30.4% compound annual growth rate (CAGR), from $11.85M to $44.66M.